PricingLoginNewsroom
Vol. II — No. 184Remarkable People · Exceptional CompaniesToday's Edition

deep-mutational-scanning

(2)
AllCompaniesPeopleStoriesProducts
Company
The Drug Hunt That Began With a Traffic Jam
Health · Ai · Enterprise

The Drug Hunt That Began With a Traffic Jam

Octant built a way to watch thousands of genetic variants misroute a protein inside living cells. Its first test is an oral drug for inherited blindness - and the wager is that one molecule can help more than one mutation.

octant-bio · biotechnologyRead →
Company
Cyrus Sold Protein Software to 120 Drugmakers. Then It Put Its Own Molecules on the Line.
Health · Ai · Enterprise

Cyrus Sold Protein Software to 120 Drugmakers. Then It Put Its Own Molecules on the Line.

The Seattle spinout made Rosetta easier for pharma scientists, learned from more than 30 partnered discovery programs, and then made a riskier bet: building its own autoimmune drugs. Its story is a useful lesson in when software should become a laboratory - and when that strategy can still fail.

protein-design · computational-biologyRead →